IP Verse

Deva competitive analysis

Latest oppositions filed by Deva

Explore patent oppositions filed by Deva against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 3, 2026
Patent NumberTitleApplicantOpposition Date
EP4346818
Solid Dosage Forms And Dosing Regimens Comprising (2R,3S,4S,5R)-4-[[3-(3,4-Difluoro-2-Methoxy-Phenyl)-4,5-Dimethyl-5-(Trifluoromethyl) Tetrahydrofuran-2-Carbonyl]Amino]Pyridine-2-CarboxamideVERTEX PHARMACEUTICALS INCORPORATEDSep 2, 2026
EP4349406
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A MedicamentPFIZERSep 2, 2026
EP2396005
Sglt-2 Inhibitor For Treating Type 1 Diabetes Mellitus, Type 2 Diabete Mellitus, Impaired Glucose Tolerance Or HyperglycemiaBOEHRINGER INGELHEIMAug 25, 2026
EP3500575
Crystalline Form Of (S)-7-(1-Acryloylpiperidin-4-Yl)-2-(4-Phenoxyphenyl)-4,5,6,7-Tetra-Hydropyrazolo[1,5-A]Pyrimidine-3-Carboxamide, Preparation, And Uses ThereofBEIGENEAug 4, 2026
EP3858859
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 28, 2026
EP4188389
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECAJun 11, 2026
EP3756650
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEMay 13, 2026
EP3689365
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKApr 28, 2026
EP3377534
Treatment Of Lung Cancer Using A Combination Of An Anti-Pd-1 Antibody And An Anti-Ctla-4 AntibodyBRISTOL MYERS SQUIBBMar 11, 2026
EP4338805
Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin TherapyAMARIN PHARMACEUTICALS IRELANDFeb 26, 2026

Latest PTAB cases involving Deva

Discover the latest PTAB cases involving Deva, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Deva with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
DEVAN CHEMICALS2 - - -
CHRISAL - 1 - -
HEIQ CHRISAL - 1 - -
OUTLAST - 2 - -